Ruijin Hospital

This study compares three common heart medications (nicorandil, diltiazem, and isosorbide mononitrate) to see which one best prevents spasms in the new artery used during bypass surgery. About 150 adults who recently had coronary artery bypass grafting with a radial artery graft …

This early-phase trial is testing a new drug called CS01 in about 10 people with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety and find the right dose, while also looking for signs that it can shrink tumors. Th…

This study tests whether a blood test that measures CMV-specific immunity can help doctors decide how long to use the antiviral drug letermovir after a stem cell transplant. The goal is to prevent late-onset CMV infection, a common and serious complication. The trial involves 250…

This study tests whether adding two newer drugs (apatinib and camrelizumab) to standard chemotherapy before and after surgery can improve outcomes for people with advanced stomach or gastroesophageal junction cancer. About 580 adults with previously untreated, locally advanced di…

This study looks at how well a treatment called CNCT-19 works for adults with a type of blood cancer called B-cell acute lymphoblastic leukemia. Researchers will review medical records from 275 patients to see how many achieve remission and how long it lasts. The goal is to under…

This study tests a gentle, non-invasive brain stimulation method called Temporal Interference Stimulation (TIS) in 40 people with early-stage Alzheimer's. Participants receive either real or fake stimulation for 2 weeks, and researchers check thinking skills and safety right afte…

This study tests a gentle, non-invasive brain stimulation technique called tTIS in 100 people with early to mid-stage Parkinson's disease. The goal is to see if it can improve movement problems like tremors and stiffness when medication is paused. Researchers will compare stimula…

This study follows 500 heart bypass patients for 10 years to see if taking two blood thinners (ticagrelor plus aspirin) for one year after surgery reduces the risk of heart attacks, strokes, or death compared to taking just one. Participants will be contacted by phone to report t…